losartan has been researched along with deoxyglucose in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ebina, Y; Houchi, H; Ishizawa, K; Kishi, K; Minakuchi, K; Nakaya, Y; Takishita, E; Tamaki, T; Tsuchiya, K; Yoshizumi, M | 1 |
Han, HJ; Heo, JS; Lee, YJ | 1 |
2 other study(ies) available for losartan and deoxyglucose
Article | Year |
---|---|
Effects of losartan in combination with or without exercise on insulin resistance in Otsuka Long-Evans Tokushima Fatty rats.
Topics: Adipocytes; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Blotting, Western; Body Weight; Deoxyglucose; Diabetes Mellitus, Type 2; Enzyme Activation; Glucose; Glucose Tolerance Test; Glucose Transporter Type 4; Heart Rate; Insulin; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Losartan; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Physical Conditioning, Animal; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred OLETF | 2001 |
ANG II increases 2-deoxyglucose uptake in mouse embryonic stem cells.
Topics: Alkaline Phosphatase; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biological Transport; Calcimycin; Calcium; Cell Line; Cell Proliferation; Deoxyglucose; DNA-Binding Proteins; Dose-Response Relationship, Drug; Embryo, Mammalian; Estrenes; Gene Expression; Glucose Transporter Type 1; Imidazoles; Inositol Phosphates; Losartan; Membrane Transport Proteins; Mice; Monosaccharide Transport Proteins; Neomycin; Octamer Transcription Factor-3; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridines; Pyrrolidinones; Stem Cells; Transcription Factors; Type C Phospholipases; Vasoconstrictor Agents | 2005 |